These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14632811)

  • 1. Pulsed ultrasound measurements of depth and regression of basal cell carcinomas after photodynamic therapy: relationship to probability of 1-year local control.
    Moore JV; Allan E
    Br J Dermatol; 2003 Nov; 149(5):1035-40. PubMed ID: 14632811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive pulsed ultrasound quantification of the resolution of basal cell carcinomas after photodynamic therapy.
    Allan E; Pye DA; Levine EL; Moore JV
    Lasers Med Sci; 2002; 17(4):230-7. PubMed ID: 12417976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound guided ablative-laser assisted photodynamic therapy of basal cell carcinoma (US-aL-PDT).
    Smucler R; Kriz M; Lippert J; Vlk M
    Photomed Laser Surg; 2012 Apr; 30(4):200-5. PubMed ID: 22316283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
    Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
    J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single treatment of low-risk basal cell carcinomas with pulsed dye laser-mediated photodynamic therapy (PDL-PDT) compared with photodynamic therapy (PDT): A controlled, investigator-blinded, intra-individual prospective study.
    Čarija A; Puizina-Ivić N; Vuković D; Mirić Kovačević L; Čapkun V
    Photodiagnosis Photodyn Ther; 2016 Dec; 16():60-65. PubMed ID: 27516420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response.
    Fantini F; Greco A; Del Giovane C; Cesinaro AM; Venturini M; Zane C; Surrenti T; Peris K; Calzavara-Pinton PG
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):896-901. PubMed ID: 21054566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy in the management of basal cell carcinoma: Retrospective evaluation of outcome.
    Jerjes W; Hamdoon Z; Hopper C
    Photodiagnosis Photodyn Ther; 2017 Sep; 19():22-27. PubMed ID: 28442314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency 40-MHz ultrasound. A possible noninvasive method for the assessment of the boundary of basal cell carcinomas.
    Gupta AK; Turnbull DH; Foster FS; Harasiewicz KA; Shum DT; Prussick R; Watteel GN; Hurst LN; Sauder DN
    Dermatol Surg; 1996 Feb; 22(2):131-6. PubMed ID: 8608374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reflectance confocal microscopy allows in vivo real-time noninvasive assessment of the outcome of methyl aminolaevulinate photodynamic therapy of basal cell carcinoma.
    Venturini M; Sala R; Gonzàlez S; Calzavara-Pinton PG
    Br J Dermatol; 2013 Jan; 168(1):99-105. PubMed ID: 23013443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment.
    Horn M; Wolf P; Wulf HC; Warloe T; Fritsch C; Rhodes LE; Kaufmann R; De Rie M; Legat FJ; Stender IM; Solér AM; Wennberg AM; Wong GA; Larkö O
    Br J Dermatol; 2003 Dec; 149(6):1242-9. PubMed ID: 14674903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
    Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
    Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up.
    Christensen E; Skogvoll E; Viset T; Warloe T; Sundstrøm S
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):58-66. PubMed ID: 18803580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial.
    Wang I; Bendsoe N; Klinteberg CA; Enejder AM; Andersson-Engels S; Svanberg S; Svanberg K
    Br J Dermatol; 2001 Apr; 144(4):832-40. PubMed ID: 11298545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source.
    Varma S; Wilson H; Kurwa HA; Gambles B; Charman C; Pearse AD; Taylor D; Anstey AV
    Br J Dermatol; 2001 Mar; 144(3):567-74. PubMed ID: 11260016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial.
    Surrenti T; De Angelis L; Di Cesare A; Fargnoli MC; Peris K
    Eur J Dermatol; 2007; 17(5):412-5. PubMed ID: 17673385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor thickness predicts long-term complete response of facial basal cell carcinomas in Asian skin types iv/v treated with methyl aminolaevulinate photodynamic therapy.
    Li Q; Gao T; Jiao B; Hu X; Luan Q; Li K; Ma C; Li C; Wang S
    Photomed Laser Surg; 2011 Jul; 29(7):501-7. PubMed ID: 21456944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facial basal cell carcinomas recurring after photodynamic therapy: a retrospective analysis of histological subtypes.
    Fiechter S; Skaria A; Nievergelt H; Anex R; Borradori L; Parmentier L
    Dermatology; 2012; 224(4):346-51. PubMed ID: 22759732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confocal microscopy insights into the treatment and cellular immune response of Basal cell carcinoma to photodynamic therapy.
    Longo C; Casari A; Pepe P; Moscarella E; Zalaudek I; Argenziano G; Pellacani G
    Dermatology; 2012; 225(3):264-70. PubMed ID: 23257915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma.
    Cosgarea R; Susan M; Crisan M; Senila S
    J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):980-4. PubMed ID: 22738399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.